Transforming CLL management with immunotherapy: Investigating the potential of CAR T-cells and bispecific antibodies
Azra Borogovac, Tanya Siddiqi
Topics & Concepts
Chimeric antigen receptorMedicineImmunotherapyChronic lymphocytic leukemiaIbrutinibImmunologyT cellAntigenTumor microenvironmentCD19Cell therapyB cellLeukemiaAntibodyCancer researchImmune systemCellBiologyGeneticsCAR-T cell therapy researchChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment